Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

McKinsey
Baxter
Harvard Business School
Boehringer Ingelheim
Merck
Express Scripts

Last Updated: November 20, 2019

DrugPatentWatch Database Preview

Drugs in MeSH Category Contrast Media

See Plans and Pricing

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Bayer Hlthcare UROVIST CYSTO PEDIATRIC diatrizoate meglumine SOLUTION;URETERAL 087731-001 Sep 23, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Bracco CYSTOGRAFIN DILUTE diatrizoate meglumine SOLUTION;URETHRAL 010040-022 Nov 9, 1982 RX Yes No   Start Trial   Start Trial   Start Trial
Cook Imaging IOPAMIDOL-370 iopamidol INJECTABLE;INJECTION 074881-004 Jul 28, 2000 DISCN No No   Start Trial   Start Trial   Start Trial
Bracco VARIBAR PUDDING barium sulfate PASTE;ORAL 208844-001 Oct 14, 2016 RX No No   Start Trial   Start Trial   Start Trial
Hospira IOPAMIDOL-250 IN PLASTIC CONTAINER iopamidol INJECTABLE;INJECTION 074636-002 Dec 30, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
Bayer Hlthcare UROVIST CYSTO diatrizoate meglumine SOLUTION;URETERAL 087729-001 Sep 23, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa IOPAMIDOL-300 iopamidol INJECTABLE;INJECTION 074679-002 Apr 2, 1997 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
Harvard Business School
McKinsey
AstraZeneca
Medtronic
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.